NASDAQ: IKT
Inhibikase Therapeutics Inc (IKT) average volume reaches $375.94K: Are the Stars Lining Up for Investors?
Zack King
Witnessing the stock’s movement on the chart, on Wednesday, Inhibikase Therapeutics Inc (NASDAQ: IKT) had a quiet start as it ...
Inhibikase Therapeutics Inc (IKT) volume exceeds 1.29 million: A new investment opportunity for investors
Sana Meer
On Monday, Inhibikase Therapeutics Inc (NASDAQ: IKT) was -3.49% drop from the session before settling in for the closing price ...
3.85% percent quarterly performance for Inhibikase Therapeutics Inc (IKT) is not indicative of the underlying story
Steve Mayer
Inhibikase Therapeutics Inc (NASDAQ: IKT) kicked off on Monday, up 5.19% from the previous trading day, before settling in for ...
